Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07014176 · ClinicalTrials.gov registry record · Phase 4
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
A Phase 4 study of Diabetic Foot Ulcer, sponsored by Cellution Biologics.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 8
- Study locations
NCT07014176 is a Phase 4 study of Diabetic Foot Ulcer that is actively recruiting participants, run by Cellution Biologics. The registered enrollment target is 120 participants, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (53% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT07014176, a Phase 4 study of Diabetic Foot Ulcer, is actively recruiting participants, sponsored by Cellution Biologics.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to determine how well our dHPT (Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot.
Conditions Studied
Interventions
- OTHER Amnion-Intermediate-Chorion
- PROCEDURE Standard of Care (SOC)
Study Locations (8)
North Carolina
- 007 - Mooresville
- 002 - Rocky Mount
Pennsylvania
- 008 - Allentown
- 004 - Philadelphia
California
- 005 - Santa Rosa
Florida
- 001 - Jacksonville
Illinois
- 003 - Chicago
South Carolina
- 006 - Hilton Head Island
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-07-03 |
| Est. Completion | 2026-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07014176
The ClinicalTrials.gov registry entry for NCT07014176 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (53% lower). The listed sponsor is Cellution Biologics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Amnion-Intermediate-Chorion is the first listed.
NCT07014176 reports 8 study locations spanning 6 distinct geographic areas - top geographies include North Carolina, Pennsylvania, California.
Frequently Asked Questions
What is clinical trial NCT07014176 about?
NCT07014176 is a clinical study titled "Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)". The purpose of this study is to determine how well our dHPT (Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot.
What is the current status of trial NCT07014176?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2025-07-03. Estimated completion is 2026-10-31.
What conditions does trial NCT07014176 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT07014176?
The interventions under investigation include: Amnion-Intermediate-Chorion (OTHER), Standard of Care (SOC) (PROCEDURE).
Who is sponsoring clinical trial NCT07014176?
This trial is sponsored by Cellution Biologics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07014176 being conducted?
This trial has 8 study locations across California, Florida, Illinois, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
RECRUITING · Phase 4
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.